CAR T-cell therapy is an immunotherapy which can cure patients with aggressive blood cancers.  However, until now, it hadn't been proven effective against solid tumours.  Researchers have used gene ...

Anita Turk, MD, discusses what she is most excited about regarding immunotherapy in the realm of colorectal cancer treatment.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer. The approval is for the use of ...

Research by Weizmann Institute scientist and Israel Prize winner saved 'countless lives,' was basis for technology sold for ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

British drugmaker AstraZeneca (LSE: AZN) has gained European approval for Imfinzi (durvalumab) in combination with ...